Palo Alto Investors’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,303,668
Closed -$131M 52
2014
Q4
$131M Sell
1,303,668
-540,020
-29% -$42M 7.7% 3
2014
Q3
$122M Buy
1,843,688
+316,772
+21% +$20.8M 9.14% 3
2014
Q2
$107M Buy
1,526,916
+157,705
+12% +$10.7M 7.94% 4
2014
Q1
$100M Buy
1,369,211
+33,075
+2% +$2.47M 8.28% 5
2013
Q4
$92M Buy
1,336,136
+321,525
+32% +$20.8M 8.58% 4
2013
Q3
$64.5M Buy
1,014,611
+257,790
+34% +$15.6M 6.76% 5
2013
Q2
$36.5M Buy
+756,821
New +$37.2M 4.31% 9

Palo Alto Investors's CBST Position: Q1 2015 in Review

Palo Alto Investors sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 1,303,668 shares — an estimated $131M sold.

Palo Alto Investors first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $131M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Palo Alto Investors reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Palo Alto Investors sold 1,303,668 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $131M.
  • Palo Alto Investors first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Palo Alto Investors's CUBIST PHARMACEUTICALS INC position peaked at $131M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Palo Alto Investors's 13F filing for Q1 2015, filed 15 May 2015.